Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-24-001626

VP, Chief Accounting Officer gave up 756 shares (to pay taxes)

  • VP, Chief Accounting Officer acquired 1,841 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2024-01-13 Option exercise +552 55,374 D: show line 1 in the form
Peraza Lisa VP, Chief Accounting Officer 2024-01-13 Option exercise +1,289 56,663 D: show line 2 in the form
Peraza Lisa VP, Chief Accounting Officer 2024-01-13 Shares withheld for taxes −756 $2.15 $1,625 55,907 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2024-01-13 Option exercise · Restricted Stock Units −552 1,656 D: show line 4 in the form
Peraza Lisa VP, Chief Accounting Officer 2024-01-13 Option exercise · Restricted Stock Units −1,289 6,675 D: show line 5 in the form
Loading xslF345X05/doc4.xml…